Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
PubMed Central PMCID: PMC4918824
2016 Jan-Feb
Formula: C21H23N3O3
(2010) Leukemia
SRX3207 potently inhibited Syk and PI3K signaling and augmented the anti-tumor immune response in lung carcinoma tumor model with no toxicity
Navitoclax-piperazine l 3 (>90%) PubMed Central PMCID: PMC4918824Navitoclax piperazine (ABT 263 piperazine) is a B cell lymphoma extra large (BCL XL) inhibitor. Navitoclax piperazine and a VHL ligand for the E3 ubiquitin ligase can be used in the synthesis of PROTAC DT2216 (HY 130604). Product information CAS Number: 2143096 93 7 Molecular Weight: 973. 63 Formula: C47H56ClF3N6O5S3 Chemical Name: 4 (4 {[2 (4 chlorophenyl) 5,5 dimethylcyclohex 1 en 1 yl]methyl}piperazin 1 yl) N (4 {[(2R) 1 (phenylsulfanyl) 4
US$ 19.00
US$ 19.00
US$ 28.00
US$ 1182.50
US$ 32.50
US$ 15.00
US$ 18.99
US$ 30.00
US$ 18.00
US$ 16.99
US$ 16.99